Morgan Stanley (NYSE:MS | MS Price Prediction) stock got a vote of confidence this morning from UBS (NYSE:UBS), which upgraded shares from Neutral to Buy with a price target of $196. With Morgan Stanley shares trading at $166.55 as of April 6, that target implies roughly 18% upside from current levels. UBS analyst Erika Najarian sees the recent pullback as an opportunity rather than a warning sign.
The upgrade arrives as bank stocks face broad selling pressure tied to the Iran conflict, private credit concerns, and AI disruption fears. Morgan Stanley shares are down 6.5% year-to-date, even after a 64% gain over the past year. The VIX currently sits at 23.87, reflecting elevated but not extreme market anxiety.
| Ticker | Company | Firm | Action | Old Rating | New Rating | Old Target | New Target |
|---|---|---|---|---|---|---|---|
| MS | Morgan Stanley | UBS | Upgrade | Neutral | Buy | $195 | $196 |
The Analyst’s Case
Najarian’s thesis centers on Morgan Stanley’s resilience amid market headwinds, its history of embracing new technologies, and its positioning to benefit from banking sector deregulation. She argues the firm has “catalysts ahead to reignite” the shares, pointing specifically to strength in advisory, the potential for blockbuster IPOs this year, and a wealth franchise that “leads peers.” The upgrade is contrarian given the current consensus Hold rating across Wall Street.
The firm’s most recent results back up that confidence. Morgan Stanley delivered full-year 2025 revenues of $70.6 billion and EPS of $10.21, with a return on tangible common equity of 21.6%. Investment Banking revenues surged 47% year-over-year in Q4 2025, and total client assets reached $9.3 trillion.
Company Snapshot
Morgan Stanley operates through three segments: Institutional Securities, Wealth Management, and Investment Management. Its Wealth Management arm generated $8.429 billion in revenue in Q4 2025, while the firm’s brands include E*TRADE, Parametric, Eaton Vance, and Morgan Stanley at Work. The firm’s CET1 ratio stands at 15.0%, signaling a well-capitalized balance sheet.
Why the Move Matters Now
At a trailing P/E ratio of 16x and a forward P/E ratio of 15x, Morgan Stanley shares trade at a meaningful discount to their 52-week high of $191.62. The firm is targeting $10 trillion or more in total client assets, and an IPO rebound could accelerate that path. That’s a compelling setup for investors who believe the current sell-off is cyclical rather than structural.
What It Means for Your Portfolio
If you’re an income-focused investor, Morgan Stanley’s $1.00 per share quarterly dividend and a dividend yield of 2.37% offer a steady income stream while you wait for the thesis to play out. The firm repurchased $4.585 billion in shares during full-year 2025, reflecting management’s own confidence in the valuation. You’d want to own Morgan Stanley if you believe the IPO pipeline reopens and deregulation tailwinds materialize; if macro headwinds deepen, patience will be required.
The UBS upgrade is notable precisely because it comes during a period of broad financial sector weakness. Analysts who issue Buy ratings into a sell-off are staking their credibility on a recovery, and Najarian’s call reflects a view that Morgan Stanley’s diversified model — spanning trading, wealth, and investment management — provides resilience that pure-play investment banks lack.
Top Gaining Stocks
Top Losing Stocks